Olaparib
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09074 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | female breast carcinoma | KG + DL |
| 2 | gonadal germ cell tumor | KG + DL |
| 3 | ovarian primitive germ cell tumor | KG + DL |
| 4 | choriocarcinoma of ovary | KG + DL |
| 5 | ovarian neoplasm | KG + DL |
| 6 | ovarian malignant mesothelioma | KG + DL |
| 7 | malignant non-epithelial tumor of ovary | KG + DL |
| 8 | ovarian cancer, susceptibility to, 1 | KG + DL |
| 9 | ovarian adenosarcoma | KG + DL |
| 10 | ovarian Sertoli-Leydig cell tumor | KG + DL |
| 11 | ovarian thecoma | KG + DL |
| 12 | ovarian endometrioid adenocarcinofibroma | KG + DL |
| 13 | fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement | KG + DL |
| 14 | adult germ cell tumor | KG + DL |
| 15 | childhood ovarian yolk sac tumor | KG + DL |
| 16 | testicular yolk sac tumor, hepatoid pattern | KG + DL |
| 17 | testicular yolk sac tumor, solid pattern | KG + DL |
| 18 | polyvesicular vitelline pattern testicular yolk sac tumor | KG + DL |
| 19 | testicular yolk sac tumor, papillary pattern | KG + DL |
| 20 | testicular yolk sac tumor, endodermal sinus pattern | KG + DL |
| 21 | reticular pattern testicular yolk sac tumor | KG + DL |
| 22 | testicular yolk sac tumor, macrocystic pattern | KG + DL |
| 23 | enteric pattern testicular yolk sac tumor | KG + DL |
| 24 | malignant ovarian cyst | KG + DL |
| 25 | ovarian yolk sac tumor, hepatoid pattern | KG + DL |
| 26 | ovarian yolk sac tumor, glandular pattern | KG + DL |
| 27 | ovarian yolk sac tumor, polyvesicular vitelline pattern | KG + DL |
| 28 | mediastinal malignant germ cell tumor | KG + DL |
| 29 | urethra clear cell adenocarcinoma | KG + DL |
| 30 | ovarian gonadoblastoma (disease) | KG + DL |
| 31 | ovarian Wilms tumor | KG + DL |
| 32 | pancreatic neoplasm | KG + DL |
| 33 | cervical clear cell adenocarcinoma | KG + DL |
| 34 | breast-ovarian cancer, familial, susceptibility to | KG + DL |
| 35 | gonadoblastoma | KG + DL |
| 36 | exocrine pancreatic carcinoma | KG + DL |
| 37 | ovarian cystic teratoma | KG + DL |
| 38 | malignant pancreatic neoplasm | KG + DL |
| 39 | ovarian gynandroblastoma | KG + DL |
| 40 | urethral valve | KG + DL |
| 41 | ovarian mixed germ cell neoplasm | KG + DL |
| 42 | ovarian teratoma | KG + DL |
| 43 | ovarian sex cord-stromal tumor | KG + DL |
| 44 | endometrial clear cell adenocarcinoma | KG + DL |
| 45 | malignant struma ovarii | KG + DL |
| 46 | pediatric ovarian germ cell tumor | KG + DL |
| 47 | mixed germ cell tumor | KG + DL |
| 48 | non-gestational ovarian choriocarcinoma | KG + DL |
| 49 | malignant teratoma | KG + DL |
| 50 | ovarian biphasic or triphasic teratoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.